GCR Interactive: Pharmaceuticals – Collision of Biologics


With the biologics market a growing focus of development across the globe, what role does antitrust have to play in order to ensure healthy price competition between reference-priced biologics and competing biosimilars?

Hendrik Viaene speaks in this session which will focus on this role, and what lessons can and cannot be learned from generics, to help ensure low cost versions are available to all.

David Giardina, Sidley Austin

Sheng Li, NERA Economic Consulting
Elaine Johnston, Allen & Overy
Hendrik Viaene, McDermott, Will & Emery

For more information, and to register, please click here.

Dig Deeper

Webinar / McDermott Event / April 27 - June 8, 2021

2021 Life Sciences Bootcamp Series

Webinar / Speaking Engagements / March 31, 2021

Contracting in Biotech and Pharmaceutical Manufacturing

Webinar / Speaking Engagements / March 11, 2021

GCR Interactive: Pharmaceuticals - Collision of Biologics

Webinar / Cancer Treatment Centers of America / February 25, 2021

CTCA's Understanding and Addressing Health Disparities in Cancer Care (LIVE Webcast)

Virtual Event / Speaking Engagements / January 7 & 11-13, 2021

2021 J.P. Morgan Healthcare Conference

Get In Touch